The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Tornier's revenues will grow 15.1% and EPS will remain in the red.
The average estimate for revenue is $76.0 million. On the bottom line, the average EPS estimate is -$0.10.
Last quarter, Tornier notched revenue of $82.7 million. GAAP reported sales were 11% higher than the prior-year quarter's $74.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, non-GAAP EPS came in at -$0.10. GAAP EPS were -$0.17 for Q1 versus $0.00 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 73.6%, 200 basis points better than the prior-year quarter. Operating margin was -1.6%, 330 basis points worse than the prior-year quarter. Net margin was -8.3%, 810 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $312.3 million. The average EPS estimate is -$0.30.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 15 members out of 20 rating the stock outperform, and five members rating it underperform. Among eight CAPS All-Star picks (recommendations by the highest-ranked CAPS members), six give Tornier a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Tornier is outperform, with an average price target of $21.89.
Is Tornier the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Tornier to My Watchlist.